Axsome Therapeutics (NASDAQ:AXSM) Coverage Initiated at Oppenheimer
Equities research analysts at Oppenheimer began coverage on shares of Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat.com reports. The brokerage set an “outperform” rating and a $185.00 price target on the stock. Oppenheimer’s price objective suggests a potential upside of 71.07% from the company’s previous […]
Equities research analysts at Oppenheimer began coverage on shares of Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) in a research note issued to investors on Tuesday, MarketBeat.com reports. The brokerage set an “outperform” rating and a $185.00 price target on the stock. Oppenheimer’s price objective suggests a potential upside of 71.07% from the company’s previous […]
